Appointment New Patient Appointment or 214-645-8300

MedBlog

James Brugarolas, M.D., Ph.D.

Cancer

New immunotherapy drug combination is a significant advancement in kidney cancer therapy

A new immunotherapy drug combination has been dubbed a significant advancement in kidney cancer treatment. The combination of ipilimumab and nivolumab can improve outcomes and quality of life. Learn more.

Cancer

The Team That's Doubling Cancer Survival Rates